Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Agilent Technologies Invests US $725 million for Facility Expansion in Colorado
Agilent Technologies has selected Fluors Advanced Technologies and Life Sciences business to expand its oligonucleotide therapeutics production plant in Colorado, according to a release from Fluor As part of the project, Fluor is providing engineering and procurement support The project is worth $725 million in total
Alcami Constructs New cGMP Biostorage Facility in the USA
Alcami is set to start the construction of a new 65,000squarefoot cGMP storage facility in North Carolina, USA This new facility will make use of the leading biostorage systems and procedures from Alcamis Masy division It will also have high levels of redundancy in order to safeguard customerowned materials
Novo Nordisk to Expand Clinical Manufacturing Facilities in Denmark
The expansion of existing buildings in Bagsvaerd, Denmark, will cost Novo Nordisk US $077 billion The plans also include the construction of a new plant located in the extension of the existing facilities The investment will create more RD manufacturing capability for our global clinical trials
Almac Group Invests US $65 million for Clinical Facility Expansion in the USA
In order to expand its clinical supply operations, Almac Group invested US $65 million at the companys North American headquarters in Souderton, Pennsylvania With additional cold and ultralow storage and justintime processing capabilities, the 100,000 ft2 facility will increase the facilitys clinical capacity
Synthego Begins Work on a Manufacturing Facility in the USA
Synthego has started work on a 20,000squarefoot manufacturing facility in the USA The facility, which will be situated in the San Francisco Bay region, will enable the company to enhance the manufacturing of its gene editing tools by expanding the Halo platform
WuXi STA Begins Pharmaceutical Manufacturing Facility Construction in USA
WuXi STA has begun construction of a new 190acre pharmaceutical manufacturing campus in Middletown, Delaware, in the United States This location will be WuXi STAs second in the country, providing increased flexibility and capacity to meet the demands of clients in the US and beyond
Catalent Invests US$ 2.2 million for Clinical Supply Facility in Singapore
Catalent invested US$22 million for the expansion of its clinical supply facilities in Singapore The investment will allow the installation of 35 new freezers for ultralow temperature ULT storage, expanding the sites footprint by over 20 to 31,000 square feet
Merck Invests more than US$130 million for Manufacturing Facility Expansion in France
Merck has invested more than US$130 million to improve its production capabilities for singleuse assemblies in Molsheim, France The expansion will boost production capabilities for singleuse assemblies from the Mobius portfolio
First North American Biomanufacturing Facility Opened in USA by WuXi Biologics
WuXi Biologics opened MFG18, its first GMP phase I drug substance clinical production facility, in Cranbury, New Jersey, USA With solely singleuse technology, the 154,448 square foot sites operational capacity for clinical manufacture will increase to 6,000 litres from its initial capacity of 4,000 litres
Horizon Therapeutics to Expand its Development, Manufacturing Facility in Ireland
Horizon Therapeutics plans to increase the size of its manufacturing and development facility in Waterford, Ireland The facility will increase the companys current 44,000 square foot drug product fillfinish biologics facility by about 320,000 square feet
